Early detection of diabetic retinopathy.

Surv Ophthalmol

Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

Published: September 2018

Diabetic retinopathy (DR) is a primary cause of visual impairment worldwide. Diabetes mellitus may be associated with ophthalmoscopically nonvisible neurovascular damage that progresses before the first clinical signs of DR appear. Reduction of the inner neuroretinal layer thickness on macular optical coherence tomography, reduced contrast sensitivity primarily at low spatial frequencies, abnormal results in color vision and microperimetry tests, and a prolonged implicit time recorded by multifocal electroretinography have been proposed for detection of early functional and nonvisible structural neuroretinal changes. Vascular abnormalities such as changes in the retinal vessel caliber, architectural indices, and blood flow have been investigated to evaluate the early stages of DR. The results of optical coherence tomography angiography, retinal vessel oxygen saturation patterns, and elevated levels of circulating blood markers and cytokines have been suggested as early signs of DR. Light-based molecular imaging in rodents has been developed to demonstrate changes in protein expressions in the retinal microvessels as diagnostic biomarkers. Future clinical studies will examine the safety and efficacy of this approach in humans. We summarize all the studies related to subclinical DR biomarkers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.survophthal.2018.04.003DOI Listing

Publication Analysis

Top Keywords

diabetic retinopathy
8
optical coherence
8
coherence tomography
8
retinal vessel
8
early
4
early detection
4
detection diabetic
4
retinopathy diabetic
4
retinopathy primary
4
primary visual
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!